7 Overstated
Iron supplementation during infection increases mortality, and children given iron in high-pathogen developing areas are significantly more likely to die of infection.
"And there's all sorts of data showing that, for instance, iron supplementation kills you if you're infected, or kids that are given iron in high-pathogen Third World areas are much more likely to die of infection." (said at 0:06:41)
The claim is an overstatement of findings from pediatric nutrition trials in malaria-endemic regions. The landmark 2006 Pemba trial in Zanzibar (over 24,000 children) found that routine daily iron and folic acid supplementation was associated with a 12% increased risk of the composite outcome of hospital admission or death (RR 1.12, 95% CI 1.02–1.23), primarily in iron-replete children in high-malaria settings lacking routine infection management. However, mortality alone was not statistically significantly increased (15% non-significant elevation, 95% CI -7% to 41%). Furthermore, comprehensive Cochrane systematic reviews and meta-analyses across dozens of randomized trials show that oral iron supplementation results in little to no significant difference in all-cause mortality (RR 1.15, 95% CI 0.76–1.74 for iron alone; RR 1.13, 95% CI 0.90–1.42 for iron plus folic acid). While safety concerns led public health guidelines to recommend targeting iron to iron-deficient individuals rather than universal untargeted supplementation in high-malaria zones without adequate medical care, the evidence does not show that iron supplementation 'kills you' or makes children 'much more likely to die of infection.'
- partial: Effects of routine prophylactic supplementation with iron and folic acid on admission to h… (Lancet (London, England) 2006) · cited 986x in the literature
"Those who received iron and folic acid with or without zinc were 12% (95% CI 2-23, p=0.02) more likely to die or need treatment in hospital for an adverse event and 11% (1-23%, p=0.03) more likely to be admitted to hospital; there were also 15% (-7 to 41, p=0.19) more deaths in these groups." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Oral iron supplements for children in malaria-endemic areas. (The Cochrane database of systematic reviews 2026) · cited 3x in the literature
"Iron may result in little or no difference in mortality (RR 1.15, 95% CI 0.76 to 1.74; 20 trials, 8809 children; low-certainty evidence) and hospitalisations or clinic visits (RR 0.99, 95% CI 0.95 to 1.04; 10 trials, 14,011 children; low-certainty evidence). Iron plus folic acid versus placebo/no treatment The evidence for this comparison comes largely from one large trial (Pemba) plus four smaller trials (19,456 children)... Iron plus folic acid may result in little to no difference in severe malaria requiring admission (RR 1.11, 95% CI 0.96 to 1.28; 2 trials, 17,575 children; low-certainty evidence); all-cause mortality (RR 1.13, 95% CI 0.90 to 1.42; 5 trials, 18,034 children; low-certainty evidence)" (abstract, results, passage verified)
pubmedfull study (doi)
Prior to 10,000 years ago, hominids and humans predominantly died from physical trauma rather than epidemic crowd infections like smallpox, measles, and malaria.
"if you look at the things that killed hominids and human beings before about 10,000 years ago, they were largely not the infectious agents that killed us across history, right? So most people died of things like malaria and smallpox and measles—these horrible crowd infections—over the last 10,000 years, since the invention of agriculture. Before that, most people died from trauma." (said at 0:08:38)
The speaker correctly identifies that epidemic 'crowd infections' (such as smallpox and measles) largely arose and proliferated following the agricultural transition (~10,000 years ago) due to higher population densities and animal domestication. However, the assertion that pre-agricultural humans 'predominantly died from physical trauma' rather than illness or other infectious processes is overstated. In modern and prehistoric hunter-gatherer demographic and bioarchaeological analyses, non-epidemic infectious illnesses (such as acute respiratory infections, gastrointestinal diseases, and parasite- or pathogen-related sepsis) remain leading causes of mortality across the lifespan alongside trauma, predation, and violence, rather than trauma being the sole predominant cause.
A pro-inflammatory MTHFR gene variant associated with depression risk is linked to increased survival against hepatitis B in sub-Saharan Africa.
"So we think about something like the MTHFR gene, right, that's involved in folate metabolism, right? So there's a form of it that seems to be a depression risk factor. So if you look at what it does immunologically, it is probably pro-inflammatory, and it's strongly associated with increased survival in sub-Saharan Africa because in sub-Saharan Africa, so many people initially die of hepatitis B, and the form of the gene that may be a risk factor for depression is actually protective against that illness." (said at 0:11:30)
Meta-analyses confirm a modest association between the MTHFR C677T polymorphism (T allele) and an increased risk of depression. Regarding hepatitis B, an observational comparative study in West Africa (Togo and Benin) found that the MTHFR 677T allele was associated with reduced odds of persistent chronic hepatitis B virus (HBV) infection, lower viral load, and higher anti-HBs antibody persistence. However, describing this as a strong association with increased overall survival against fatal hepatitis B in sub-Saharan Africa overstates the evidence, which comes from a single cross-sectional observational study evaluating markers of viral clearance rather than direct population survival data.
Hot baths improve autistic symptoms in children.
"And there's some interesting data on hot baths improving autistic symptoms, right? And there's people at Kids in New York, right?" (said at 0:35:28)
The idea that hot baths improve autism spectrum disorder (ASD) symptoms stems from anecdotal and pilot observations exploring whether artificial hyperthermia could mimic the purported "fever effect" in autism. However, evidence demonstrating that hot baths reliably improve autistic symptoms is lacking. Retrospective surveys (such as the Simons Simplex Collection) found parent-reported behavioral improvements during natural fevers in only about 17% of children. Furthermore, prospective studies demonstrate that fever typically worsens emotional, social, and behavioral symptoms in most children with ASD, with consistent behavioral improvements documented in only a very small minority (e.g., ~2%).
Taking NSAIDs during exercise blunts exercise-induced muscle restructuring adaptations in humans.
"Now, there's also a study, interestingly, showing that if you look at the the beneficial effects of exercise on sort of muscle restructuring, this is in humans, if you exercise and take a non-steroidal anti-inflammatory, you get rid of all those good—" (said at 0:46:09)
Human randomized controlled trials show that high daily over-the-counter doses of NSAIDs (such as 1,200 mg/day ibuprofen) attenuate, but do not completely abolish, muscle hypertrophy and strength adaptations to resistance training in young adults. For example, an 8-week trial in young adults found quadriceps hypertrophy increased by 3.7% with daily ibuprofen compared to 7.5% with low-dose aspirin. However, claiming that NSAIDs eliminate all exercise adaptations is an exaggeration. Furthermore, the effect is dose- and population-dependent: lower or intermittent doses (such as 400 mg/day) do not impair hypertrophy in young adults, and in older adults, daily ibuprofen has actually been shown to enhance resistance training-induced muscle hypertrophy and strength gains.
- contradicts: The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance t… (Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2008) · cited 96x in the literature
"We conclude that a moderate dose of ibuprofen ingested after repeated resistance training sessions does not impair muscle hypertrophy or strength and does not affect ratings of muscle soreness." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exer… (American journal of physiology. Regulatory, integrative and comparative physiology 2011) · cited 195x in the literature
"Over-the-counter doses of acetaminophen or ibuprofen, when consumed in combination with resistance training, do not inhibit and appear to enhance muscle hypertrophy and strength gains in older adults." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: High doses of anti-inflammatory drugs compromise muscle strength and hypertrophic adaptati… (Acta physiologica (Oxford, England) 2018) · cited 90x in the literature
"Maximal over-the-counter doses of ibuprofen attenuate strength and muscle hypertrophic adaptations to 8 weeks of resistance training in young adults." (abstract, conclusions, passage verified)
pubmedfull study (doi)
The human brain accounts for 30% of total energy utilization in the human body.
"these huge brains, which take up 30% of all the energy utilization in our body" (said at 1:09:40)
The adult human brain accounts for approximately 20% of the body's total basal energy and oxygen consumption despite representing only about 2% of total body weight. Stating that the human brain accounts for 30% of total body energy utilization overstates this established physiological proportion.
Studies demonstrate that among depressed patients who achieve full remission on antidepressants for two years, 60% to 80% relapse within one month if the medication is discontinued rapidly.
"you take people that have been in full remission taking an antidepressant for two years, you take it away, and 60-80% of them will relapse within a month, especially if you stop it quickly." (said at 1:28:28)
While randomized controlled trials confirm that discontinuing antidepressant therapy after long-term use significantly increases the risk of relapse compared to maintenance therapy, the claimed 60% to 80% relapse rate within a single month is substantially overstated. In the landmark ANTLER randomized trial, which evaluated primary care patients in remission after taking antidepressants for 2 years or longer, the cumulative relapse rate in the discontinuation group reached 56% over an entire 52-week (one-year) follow-up period, not within one month. Meta-analyses and discontinuation studies similarly show that while rapid discontinuation increases early relapse risk compared to slow tapering, relapse accumulates over months to years rather than affecting 60% to 80% of patients within four weeks.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.